Incorporated in 2009 and listed on the Singapore Stock Exchange, Biolidics Limited (“Biolidics” or the Company”), is a medical technology company focusing on the development of cell enrichment systems which, when combined with other analytical tests, have a wide range of applications for cancer diagnosis, prognosis, treatment selection and treatment monitoring.
